NCT05386706 is a NA clinical trial of Digital Intervention in Polycystic Ovary Syndrome, sponsored by Shanghai 10th People's Hospital.

Who is sponsoring NCT05386706?

NCT05386706 is sponsored by Shanghai 10th People's Hospital.

What drugs are being tested in NCT05386706?

Interventions in NCT05386706: Digital Intervention, Metformin.

What condition does NCT05386706 study?

NCT05386706 studies Polycystic Ovary Syndrome.

Is NCT05386706 still recruiting?

NCT05386706 is currently completed. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT05386706

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treating PCOS With Digital Intervention vs. Metformin

Completed NA Last updated 13 November 2023

What this trial tests

NA trial testing Digital Intervention in Polycystic Ovary Syndrome in 80 participants. Completed in 1 September 2023.

Timeline

21 June 2022

Primary endpoint
12 August 2023

1 September 2023

Quick facts

Lead sponsor	Shanghai 10th People's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	21 June 2022
Primary completion	12 August 2023
Estimated completion	1 September 2023
Sites	1 location across China

Drugs / interventions tested

Digital Intervention
Metformin (metformin) — full drug profile →

Conditions studied

Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →

Sponsor

Shanghai 10th People's Hospital

Who can join

Adults 18 to 45, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the change in environment and lifestyle, and the improvement of people's understanding of PCOS, the incidence of PCOS is increasing worldwide. According to statistics, the prevalence of PCOS in premenopausal women is as high as 5-20%. Lifestyle interventions are the main treatment option for patients with PCOS. In addition, research has shown that digital therapy can effectively improve behavior changes in diet, exercise, and medication adherence, predict disease progression, reduce the frequency of disease-related symptoms, and promote effective disease management. This study aimed to investigate the efficacy of digital intervention versus traditional metformin monotherapy in patients with PCOS.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Digital therapeutics in the clinic.
Phan P, Mitragotri S, Zhao Z. · · 2023 · cited 39× · PMID 37476062 · DOI 10.1002/btm2.10536
Efficacy of WeChat-Based Digital Intervention Versus Metformin in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial.
Dilimulati D, Shao X, Wang L, Cai M, et al · · 2024 · cited 8× · PMID 39357046 · DOI 10.2196/55883

Verify or expand the search:

Other trials of Digital Intervention

Trials testing the same drug.

NCT06631339 — Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN) · NA · recruiting
NCT06778785 — Game-Based Digital Intervention for Depression in Adolescents · NA · active not recruiting
NCT06349993 — Digital Intervention for Depression and Anxiety in Adolescents · NA · recruiting
NCT05667363 — Digital Therapeutics on Inhalation Medication Adherence in COPD · NA · unknown
NCT04098016 — Digital Intervention To Improve Diet Quality · NA · completed

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting

Other Shanghai 10th People's Hospital trials

Trials by the same sponsor.

NCT07528040 — An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With C · not yet recruiting
NCT07370441 — Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients · Phase 4 · not yet recruiting
NCT07328100 — Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. · NA · not yet recruiting
NCT06783296 — Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension · NA · not yet recruiting
NCT07204496 — A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05386706 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shanghai 10th People's Hospital
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing